Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
In a bid to relieve pressure on England’s medical health service NHS -- the London and Berlin-based startup Medbelle is offering private kits at cost price – with the option for people to additionally “sponsor” tests for key workers and people in need.
Coronavirus is spreading rapidly across the world killing several thousands of people in various countries.
Amid Coronavirus outbreak, Dutch software scale-up Klippa is offering its expense and invoice processing tool for free to healthcare organizations across the world.
Medical images can be analysed more accurately, more effectively, and easier using Artificial Intelligence.
Recently, the Redmond giant Microsoft has joined hands with the US Centers for Disease Control and Prevention to develop coronavirus self-checker to help people to determine whether they should go to the hospital or not when they feel sick.
Aktiia, a Swiss-US startup that develops optical blood pressure monitors at the wrist, has recently raised €5.6 million in funding.
Countries around the world are putting their best foot forward to combat the spread of Coronavirus aka Covid-19. Efforts to curb its spread have also ramped up ever since it was declared a pandemic and effective communication is, of course, crucial to help reduce the flu’s spread.
Irish tech startup SureWash has launched an augmented reality app that will ensure health professionals, general public, and workers are washing their hands correctly as suggested by the World Health Organisation (WHO) during the COVID-19 outbreak.
At a breakneck pace, hundreds of scientists around the world are working to create drugs to treat the people infected with Coronavirus.
Governments of different countries around the world are taking necessary precautions to curb the spread of Coronavirus.
The coronavirus outbreak has been labeled a pandemic by the World Health Organization (WHO) recently.
Harbour BioMed, a Cambridge, MA- Rotterdam, The Netherlands and Suzhou, China-based global, clinical-stage biopharmaceutical company, closed a $75 million (€67.4 million approx) Series B+ round of financing.
